We often talk about stem cells but there are some pretty basic, important questions that often go unanswered like where do stem cells come from?
Its a more complicated and interesting question than you might think, and some of the answers point to novel ways in which stem cells may be used to treat human diseases. Note that if you are looking for information in a language other than English, my stem cell outreach pages have key facts about stem cells in dozens of languages. The website A Closer Look at Stem Cells is also a good resource.
As a stem cell biologist myself and professor of a research lab working on stem cells for 14+ years, the origins and properties of stem cells are questions Ive been thinking about for a few decades. I enjoy discussing these issues. This post is likely to be of special interest to people or patients interested in stem cells, other stem cell biologist, scientists more generally, and students who want to learn more, perhaps for an upcoming test that will include questions on stem cells and their origins.
Lets start by discussing the adult sources of stem cells, which have great medical promise. In the old days people would widely classify stem cells as adult or embryonic, but this binary way of thinking was in part driven more by antiquated views of good and bad stem cells than by science. For instance, since induced pluripotent stem cells or IPS cells (more on them below) were not made from embryos they were sometimes classified as adult stem cells, which to me doesnt make sense.
Where can adult stem cells come from?
For todays article, well classify adult stem cells as stem cells that are from individuals who are already born but may still be children. In this sense, the term adult is a bit odd, but it seems like the best classification approach. So, for example, stem cells from the bone marrow of a six-year-old girl would be considered adult stem cells.
In addition to the examples above, one theory is that every adult tissue or organ has its own population of stem cells. In this sense, there may be stem cells right now in every part of your body including your brain, kidney, liver, lungs, etc. Scientists periodically debate whether certain organs have meaningful populations of stem cells and it seems like the topics of adult humanbrain stem cells and heart stem cells are particularly contentious. My own sense is that nearly every adult organ has stem cells, but in some cases like in the heart they may either be absent or present in such small numbers that they do not seem at this time to have much significance for health.
These adult stem cells are there for two main reasons. First, they help to maintain that particular tissue or organ. Every day some of the cells in our bodies randomly die even under normal conditions and the adult stem cells help replace those. Second, should a tissue or organ get damaged or become infected, the adult stem cells in it will help it heal.
As their name suggests, embryonic stem cells are largely generated using embryos. In the case of human embryonic stem cells, they are derived from human embryos left over from IVF procedures done to help infertile couples have babies.
These human embryos are at a very early stage of development only a few days after fertilization and have around 100 cells.
They have no specific tissues or organs yet, as those will come much later. Instead they are essentially a ball of mostly uniform cells.
While years ago humanembryonic stem cells were the source of quite a bit of debate, today they are much more widely accepted by the public including in the U.S.
Still, some folks are opposed to making or using human embryonic stem cells.
Embryonic stem cells can also be made through a process called somatic cell nuclear transfer or SCNT. In this process, the nucleus of an adult cell is transferred into an egg (or one-cell embryo) that has had its own nucleus removed. Sometimes if this all goes right the hybrid cell will go on with development normally even though it has the nucleus from another cell.
Such cloning is widely used to make more farm animals. To my knowledge it has never been used to make a human clone, but the topic often comes up. If the SCNT procedure is done with human cells, instead of trying to make a cloned person those early embryos can instead be used to make human embryonic stem cells, which could be very useful in medicine. For this reason, this process is sometimes called therapeutic cloning. It remains unclear whether SCNT-derived human embryonic stem cells are really needed given the innovation of IPS cells, which Ill now discuss.
Induced pluripotent stem cells or IPS cells were first reported using mouse and human cells in 2006 and 2007, respectively. Where do IPS cells come from? They are made through a process called reprogramming, which in a nutshell means that adult cells are transformed into IPS cells using specific molecules that have the power to convince cells they are like embryonic stem cells.
One analogy is that cellular reprogramming is sort of like installing a new operating system on your computer to make it function differently, but in the case of cells this new operating system does physically changes the resulting cells as they make new proteins, RNAs, etc.
The bottom line is that the resulting IPS cells act just like embryonic stem cells, but no embryo is needed to make them. The IPS cells can be differentiated into just about any cell type for use as therapies including making adult stem cells.
An increasing number of clinical trials are ongoing using IPS cells across the globe including both here in the US and in Japan, just to name two hubs of IPS cell work.
A related method called direct reprogramming is also in the mix. Direct reprogramming (also called dedifferentiation) in a way skips the IPS cell step.
In this way, typical adult stem cells like from blood can be directly changed into totally different kinds of cells like brain cells without having to go through the IPS cell step.
Yes, us humans are amazing in some ways with our big brains and such, but when it comes to stem cells some other animals are way cooler than us. Certain species have far more stem cells than we do and even what seem like non-stem cells in these animals can convert to a stem cell-like state under stress. While some researchers believe that in humans some non-stem cells can change into stem cells under stress like disease, this remains a more controversial idea.
One of the more amazing creatures from a stem cell perspective is the type of amphibians called axolotls. You can see a picture of an axolotl above. If they are attacked by a predator deep within their habit like a pool in a cave in Mexico and lose an arm or a leg, they have so many stem cells that they can regrow a new arm or leg. They could also regrow a new part of their head or of a damaged organ in some cases. By doing research on such creatures the hope is that it will unlock the stem cell-based regenerative potential of humans too.
In a way, whats more important than where particular stem cells come from is what those stem cells can do. A second important question goes hand-in-hand and that is what risks particular stem cells might pose. Overall, what biomedical scientists and patients should focus on is the ratio of potential benefit to potential risk. still, I understand that the source of stem cells is an important issue as well to many people.
Related
Follow this link:
Where do stem cells come from? Expert answers - The Niche
- Detection of biomagnetic signals from induced pluripotent stem cell-derived cardiomyocytes using deep learning with ... - Nature.com - April 1st, 2024
- Researchers discover new microRNA-regulated pathway to boost iPS cell-derived platelet production - Phys.org - March 30th, 2024
- Standardized production of hPSC-derived cardiomyocyte aggregates in stirred spinner flasks - Nature.com - March 28th, 2024
- Synthetic Circuits Reveal the Key to Rewinding the Cellular Clock - The Scientist - March 13th, 2024
- synNotch-programmed iPSC-derived NK cells usurp TIGIT and CD73 activities for glioblastoma therapy - Nature.com - March 3rd, 2024
- Breaking through new research barriers with iPSC technology - News-Medical.Net - February 15th, 2024
- Abu Dhabi Stem Cells Centre partners with Rege Nephro and Kyoto University's Center for iPS Cell Research and ... - Abu Dhabi Media Office - January 12th, 2024
- Abu Dhabi Stem Cells Center partners with Japan-based Kyoto University and Rege Nephro - ZAWYA - January 12th, 2024
- Efficient and reproducible generation of human induced pluripotent stem cell-derived expandable liver organoids for ... - Nature.com - December 23rd, 2023
- Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming - Nature.com - December 15th, 2023
- Shinobi Therapeutics Launches with Completion of $51M Series A to Advance Hypoimmune iPS-T Cell Therapy Platform - PR Newswire - December 13th, 2023
- CRISPRi gene modulation and all-optical electrophysiology in post-differentiated human iPSC-cardiomyocytes ... - Nature.com - December 7th, 2023
- World Hindu Congress 2023: Know all about the sessions and speakers - Organiser - November 23rd, 2023
- VCCT Inc., Leading the Field of Retinal Regeneration through iPS ... - Business Wire - November 21st, 2023
- Efficient protocol for the differentiation of kidney podocytes from ... - Nature.com - November 17th, 2023
- Vitamin B12 is a limiting factor for induced cellular plasticity and ... - Nature.com - November 17th, 2023
- Study reveals the critical role of microglia in human brain development - Medical Xpress - November 15th, 2023
- VCCT Inc., Leading the Field of Retinal Regeneration through iPS Cells, Raises 600 million Japanese yen (approximately $4 million USD) through... - November 15th, 2023
- Who are the leading innovators in iPSCs for the pharmaceutical ... - Pharmaceutical Technology - November 7th, 2023
- Using iPS Cells from I Peace, Heartseed Succeeds in Stable Production of High Purity Cardiomyocytes, A Major Step Forward in Advancing Autologous... - November 5th, 2023
- Systematic differences in discovery of genetic effects on gene ... - Nature.com - October 21st, 2023
- Pairwise biosynthesis of ion channels stabilizes excitability and ... - pnas.org - October 11th, 2023
- Scientists find multitude of genes associated with autism - The Statesman - October 9th, 2023
- Stem Cell Banking Market is Expected to Reach USD 16,474.30 ... - Digital Journal - October 7th, 2023
- Probing the individuality of cells and molecules - Open Access Government - October 5th, 2023
- Thymmune Therapeutics Receives $37M in Funding from the ... - Manchestertimes - October 3rd, 2023
- Thymmune Therapeutics Receives $37M in Funding from the ... - Business Wire - September 29th, 2023
- Less Funding to More Researchers Gets Nobel-level Results, Study ... - The Japan News - September 27th, 2023
- Brentuximab Vedotin Plus AVD Gets Positive CHMP Opinion for ... - OncLive - September 20th, 2023
- DKMS BMST Foundation India and Kokilaben Hospital unite to spread awareness about the Importance of Stem Cell Donation on World Marrow Donor Day - APN... - September 18th, 2023
- Vitamin B6 is governed by the local compartmentalization of ... - Science - September 14th, 2023
- Dolly the sheep creator Ian Wilmut dies aged 79 - BBC - September 14th, 2023
- Scientist who created Dolly the sheep dies aged 79: Professor Sir Ian Wilmut passes away five years after reve - Daily Mail - September 11th, 2023
- The global kits market is expected to grow at a CAGR of 7.4% from ... - Digital Journal - September 8th, 2023
- Eterna Therapeutics Announces Initiation of Development Activities ... - PipelineReview.com - September 8th, 2023
- Tokyo: 100 Years of Urban Regeneration / Tokyo's Nihonbashi Area ... - The Japan News - August 31st, 2023
- Transcriptome-based prediction of drugs, inhibiting ... - Nature.com - August 30th, 2023
- From the birds and the bees to IVG - The Gauntlet - August 26th, 2023
- Breakthrough creates stem cells without any memories - Freethink - August 26th, 2023
- Aging impairs the neurovascular interface in the heart - Science - August 26th, 2023
- For This Venture Capitalist, Research on Aging Is Personal; 'Bob ... - The Wall Street Journal - August 22nd, 2023
- Unleashing Potential: Illuminating the Future of Healthcare through Revolutionary Induced Pluripotent Stem Cel - openPR - August 18th, 2023
- A 'memory wipe' for stem cells may be the key to better therapies - The Conversation - August 16th, 2023
- Erasing epigenetic 'memory' to improve the quality of stem cells - FierceBiotech - August 16th, 2023
- HebeCell and Logomix Announce Collaboration for the ... - Business Wire - August 16th, 2023
- HebeCell and Logomix Announce Collaboration for the ... - Valdosta Daily Times - August 11th, 2023
- Advancing Clinical Trials with iPSC-Derived Liver Organoids - Microbioz India - August 11th, 2023
- Activation of cAMP (EPAC2) signaling pathway promotes hepatocyte ... - Nature.com - August 1st, 2023
- IPS HEART Announces Peer-Reviewed Publication in Cells of Aging Damage Reversal Showing GIVI-MPC Stem Cell Therapys Ability to Create New Skeletal... - July 30th, 2023
- Femtech in Japan: An Industry on the Rise - Femtech Insider - July 28th, 2023
- Association between enhanced carbonyl stress and decreased ... - Nature.com - July 28th, 2023
- Defects in early synaptic formation and neuronal function in Prader ... - Nature.com - July 27th, 2023
- IPS HEART Announces Peer-Reviewed Publication in Cells of ... - Business Wire - July 25th, 2023
- Cure to Autism and Alzheimer's May Be in Space, Says 1st Brazilian Scientist who Will Be on The ISS - Folha de S.Paulo - July 25th, 2023
- Futurama's Resurrection Ruins The Perfect Ending (& Shows Must ... - Looper - July 25th, 2023
- University Of Massachusetts Amherst's Team Bags Honour Of 2023 Armstrong Fund For Science Award - India Education Diary - July 20th, 2023
- Scientists working on IVG, a new reproductive method that can make human babies in labs - IndiaTimes - July 19th, 2023
- Co-transplantation of autologous Treg cells in a cell therapy for ... - Nature.com - July 13th, 2023
- Magic Valley and Biocellion Join Forces to Improve Bioreactor Tech ... - vegconomist - the vegan business magazine - July 13th, 2023
- IPS HEART Receives U.S. FDA Rare Pediatric Drug Designation for ... - Tullahoma News and Guardian - July 10th, 2023
- Hitachi : forms strategic research collaboration with Mass General Brigham in the field of regenerative medicine and GCT - Marketscreener.com - July 6th, 2023
- Cell therapy limitations with iPS-based multi-cell therapeutics - Drug Target Review - July 6th, 2023
- Remembering Dolly- The Clone Sheep On Her Birth Anniversary - Free Press Journal - July 4th, 2023
- Labs and Translational Research - UMass Medical School - June 28th, 2023
- Cellusion raises 2.83B series C round to progress iPS cell-derived ... - BioWorld Online - June 14th, 2023
- Japan-based Fujifilm introduces first-of-its-kind human iPSC-derived ... - BSA bureau - June 6th, 2023
- ALS: Parkinson's drug ropinirole may be an effective treatment - Medical News Today - June 4th, 2023
- Scientists predict lab-grown babies in five years - Kidspot - June 4th, 2023
- Lab-grown babies could become a reality within five years - Earth.com - May 26th, 2023
- Leading healthcare experts from MENA and beyond to explore the future of precision medicine in the region at PMES 23 this month - ZAWYA - May 24th, 2023
- Long-Awaited Ax-2 Mission Launches, Heads to Space Station - AmericaSpace - May 22nd, 2023
- Eterna Therapeutics and Factor Bioscience Announce New Data on ... - GlobeNewswire - May 17th, 2023
- Research Assistant job with UNITED ARAB EMIRATES ... - Times Higher Education - May 10th, 2023
- Regulation of synaptic connectivity in schizophrenia spectrum by ... - Nature.com - April 29th, 2023
- Researchers Discover Key Role of Glucose in Brain Activity - Laboratory Equipment - April 25th, 2023
- Structure of Huntington's Protein Revealed - Technology Networks - April 21st, 2023
- Study of brain immune cell infection may explain long COVID ... - NHK WORLD - April 19th, 2023
- The Mechanism That Regulates Activity of Memory Gene - Neuroscience News - April 19th, 2023
- The IPO Buzz: CytoMed Therapeutics Prices its Micro-Cap IPO at ... - IPOScoop - April 19th, 2023
- Macomics Presents its ENIGMAC Discovery Platform for Gene to Function Target Validation of Novel Macrophage Therapies at AACR - Yahoo Finance - April 19th, 2023
Recent Comments